P. John Schmid
Affiliations
- at Design Therapeutics Inc. (DSGN), 2024-03-25
- Director at Xeris Biopharma Holdings Inc. (XERS), 2024-03-15
- Director at Helix Acquisition Corp. Ii (HLXB), 2024-02-09
- Director at Anaptysbio Inc (ANAB), 2024-01-05
- at Poseida Therapeutics Inc. (PSTX), 2023-06-16
- Director at Xeris Pharmaceuticals Inc (XERS), 2021-10-05
- Director at Neos Therapeutics Inc. (NEOS), 2021-03-19
- Director at Helix Acquisition Corp (HLXA), 2020-10-20
- Chief Financial Officer at Auspex Pharmaceuticals Inc. (ASPX), 2015-05-06
- Chief Financial Officer at Trius Therapeutics Inc (TSRX), 2013-09-13
Insider Trading: Purchases See All
Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|---|
DSGN | $3.74 | 17,809 | 26,965 | 2024-03-25 | Filing | ||
DSGN | $3.62 | 9,156 | 9,156 | 2024-03-22 | Filing | ||
XERS | $2.16 | 4,500 | Director | 11,000 | 2024-03-14 | Filing | |
XERS | $1.51 | 6,500 | Director | 6,500 | 2023-11-16 | Filing |
Insider Trading: Sales See All
Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|---|
TSRX | $6.00 | 1,800 | Officer | 107,639 | 2012-06-22 | Filing | |
TSRX | $5.04 | 500 | Officer | 104,439 | 2012-03-01 | Filing | |
TSRX | $5.63 | 500 | Officer | 104,939 | 2012-02-02 | Filing | |
TSRX | $7.28 | 700 | Officer | 105,439 | 2012-01-03 | Filing | |
TSRX | $7.50 | 700 | Officer | 106,139 | 2011-12-01 | Filing |